Published in Breast Cancer Res on August 06, 2014
Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies. Mol Cancer Res (2015) 0.97
Is 5´-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer? Int Neurourol J (2015) 0.85
Evaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic Potential. Biomed Res Int (2015) 0.82
Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities. Oncotarget (2016) 0.76
Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression. Nat Commun (2016) 0.75
On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities. Pharmaceuticals (Basel) (2015) 0.75
Intracellular delivery of antibodies by chimeric Sesbania mosaic virus (SeMV) virus like particles. Sci Rep (2016) 0.75
Calcium-Oxidant Signaling Network Regulates AMP-activated Protein Kinase (AMPK) Activation upon Matrix Deprivation. J Biol Chem (2016) 0.75
Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer. Int J Mol Sci (2017) 0.75
Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines. Oncotarget (2017) 0.75
Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest (2001) 23.21
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77
AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell (2008) 16.72
Integrin signaling. Science (1999) 16.44
Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol (1994) 12.40
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell (2005) 11.19
AMPK in Health and Disease. Physiol Rev (2009) 6.38
Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science (1995) 6.35
Distinct stem cells contribute to mammary gland development and maintenance. Nature (2011) 6.32
Integrins and anoikis. Curr Opin Cell Biol (1997) 5.38
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature (2009) 5.32
5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments. Mol Cell Biol (2006) 4.28
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature (2012) 3.85
Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol Biol Cell (2007) 3.37
Integrins, oncogenes, and anchorage independence. J Cell Biol (1997) 2.86
AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J (1999) 2.75
Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS One (2008) 2.70
Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J Biol Chem (2007) 2.54
Death receptor signaling. J Cell Sci (2005) 2.21
Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family. J Biol Chem (2007) 2.12
Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene (2002) 2.01
AMPK: a contextual oncogene or tumor suppressor? Cancer Res (2013) 1.82
Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol (2012) 1.67
AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells. J Cell Mol Med (2009) 1.67
Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J Biol Chem (2002) 1.54
PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol Cell Biol (2011) 1.52
Specificity determinants for the AMP-activated protein kinase and its plant homologue analysed using synthetic peptides. FEBS Lett (1993) 1.50
AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development. Dev Cell (2009) 1.44
Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J Biol Chem (1993) 1.43
Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis. Curr Biol (1999) 1.34
Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One (2009) 1.33
Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J (2005) 1.24
Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy. Bioessays (2009) 1.23
Simian virus 40 small T antigen activates AMPK and triggers autophagy to protect cancer cells from nutrient deprivation. J Virol (2009) 1.20
Anchorage-independent culture maintains prostate stem cells. Dev Biol (2007) 1.15
Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. Am J Pathol (2004) 1.11
The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis. Cell Death Differ (2011) 1.10
The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors. Int J Cancer (2010) 1.08
The anti-apoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site. Biochemistry (2007) 1.07
Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. Am J Physiol Endocrinol Metab (2009) 1.07
Adenosine 5'-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology (2008) 1.05
AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression. J Pharmacol Sci (2008) 1.04
Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Oncogene (2012) 1.03
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. Oncogene (2007) 1.03
A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism. FEBS Lett (2008) 1.02
Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties. Oncogene (2011) 0.95
Akt inhibitor Akt-IV blocks virus replication through an Akt-independent mechanism. J Virol (2009) 0.94
Apoptosis is accompanied by changes in Bcl-2 and Bax expression, induced by loss of attachment, and inhibited by specific extracellular matrix proteins in mammary epithelial cells. Cell Growth Differ (1997) 0.91
Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter. Small GTPases (2012) 0.89
Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner. Carcinogenesis (2012) 0.89
AMP-activated protein kinase supports the NGF-induced viability of human HeLa cells to glucose starvation. Mol Biol Rep (2009) 0.77
Retracted Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell (2003) 3.56
Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One (2009) 1.33
Simian virus 40 small T antigen activates AMPK and triggers autophagy to protect cancer cells from nutrient deprivation. J Virol (2009) 1.20
Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Mol Cancer (2009) 1.20
Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. Gynecol Oncol (2006) 1.18
Evidence for a role for notch signaling in the cytokine-dependent survival of activated T cells. J Immunol (2006) 1.11
Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog. BMC Cancer (2014) 1.09
Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Cancer Res (2011) 1.02
A monoclonal antibody against human Notch1 ligand-binding domain depletes subpopulation of putative breast cancer stem-like cells. Mol Cancer Ther (2011) 1.00
Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation. Stem Cells (2013) 0.95
Calcified amorphous tumor of the heart. Indian J Pathol Microbiol (2009) 0.94
Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation. J Virol (2004) 0.93
BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation. J Biosci (2009) 0.92
Regulation of protumorigenic pathways by insulin like growth factor binding protein2 and its association along with β-catenin in breast cancer lymph node metastasis. Mol Cancer (2013) 0.88
Competing views on cancer. J Biosci (2014) 0.86
Loss of zebrafish lgi1b leads to hydrocephalus and sensitization to pentylenetetrazol induced seizure-like behavior. PLoS One (2011) 0.86
Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma. Am J Reprod Immunol (2008) 0.85
Elevated serum haptoglobin is associated with clinical outcome in triple-negative breast cancer patients. Asian Pac J Cancer Prev (2012) 0.83
Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells. Int J Gynecol Cancer (2012) 0.83
Antibodies against the extracellular domain of human Notch1 receptor reveal the critical role of epidermal-growth-factor-like repeats 25-26 in ligand binding and receptor activation. Biochem J (2013) 0.82
Overexpression of periostin and lumican in esophageal squamous cell carcinoma. Cancers (Basel) (2010) 0.80
Evaluation of protein expression pattern of stanniocalcin 2, insulin-like growth factor-binding protein 7, inhibin beta A and four and a half LIM domains 1 in esophageal squamous cell carcinoma. Cancer Biomark (2013) 0.80
Toll-like receptors 7, 8, and 9 expression and function in primary human cervical cancer Langerhans cells: evidence of anergy. Int J Gynecol Cancer (2013) 0.80
Evaluation of immunohistochemistry and enzyme linked immunosorbent assay for HER-2/neu expression in breast carcinoma. Indian J Clin Biochem (2008) 0.79
Bone marrow involvement at presentation in pediatric non-haematological small round cell tumours. Indian J Pathol Microbiol (2007) 0.79
Development of novel peptide inhibitor of Lipoxygenase based on biochemical and BIAcore evidences. Biochim Biophys Acta (2008) 0.78
Studies on the histopathological changes in selected tissues of fish Labeo rohita exposed to phenol. J Environ Biol (2013) 0.78
Phosphotyrosine profiling identifies ephrin receptor A2 as a potential therapeutic target in esophageal squamous-cell carcinoma. Proteomics (2015) 0.77
Recapitulating tumour microenvironment in chitosan-gelatin three-dimensional scaffolds: an improved in vitro tumour model. J R Soc Interface (2012) 0.77
Follicular dendritic cell tumour--a case report. Indian J Pathol Microbiol (2003) 0.75
Cytogenetic study of non-Hodgkin lymphoma from South India. histologic and geographic correlations. Cancer Genet Cytogenet (2003) 0.75
Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma. Sci Rep (2017) 0.75
Gum hypertrophy - an unusual presenting feature in a case of precursor T-cell acute lymphoblastic leukemia. Turk J Haematol (2008) 0.75